Skip to main content
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · CTXR ISIN · US17322U2078 LEI · 5493005C10W36P4KQP40 US Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2011-08-26 Interim / Quarterly Rep…
Country US United States of America
Listing US CTXR

About Citius Pharmaceuticals, Inc.

https://www.citiuspharma.com/

Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company that develops and commercializes critical care products. The company's diversified pipeline focuses on anti-infectives in adjunct cancer care, stem cell therapies, and prescription products. Its portfolio includes LYMPHIR™, an FDA-approved therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Key product candidates in development include Mino-Lok®, an antibiotic lock solution intended to treat patients with catheter-related bloodstream infections, and Halo-Lido, a topical formulation for the treatment of hemorrhoids. Additionally, the company is advancing a stem cell therapy platform for conditions such as acute respiratory distress syndrome (ARDS).

Recent filings

Filing Released Lang Actions
FORM 10Q
Interim / Quarterly Report Q3 2011
2011-08-26 English
Regulatory Filings 2011
Regulatory Filings
2011-07-13 English
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date for a Registration Statement on Form S-1. It references Rule 461 under the Securities Act of 1933 and discusses procedural matters related to the filing's effectiveness. There is no financial data, report content, or detailed disclosures typical of an Annual Report, Interim Report, or other substantive filings. The document is short (1894 characters) and serves as a formal communication about the registration statement's effective date, not the report itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2011-07-11 English
TRAIL ONE, INC,
Capital/Financing Update Classification · 95% confidence The document is a Form S-1A Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes a preliminary prospectus, detailed company information, risk factors, management discussion, financial statements, and other disclosures typical of a registration statement for an initial public offering or resale of shares. This type of filing is related to capital raising activities and financing. It is not an annual report, earnings release, or any other report type listed. The closest fitting category is Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2011-07-07 English
Regulatory Filings 2011
Regulatory Filings Classification · 100% confidence The document is a letter from Trail One, Inc. to the SEC responding to comments on an Amendment No. 6 to a Registration Statement on Form S-1. It discusses details about the company's burn rate, funding, financial disclosures, and amendments to the S-1 filing. The Form S-1 is a registration statement used for securities offerings, not a financial report like an annual or quarterly report. The document is a correspondence addressing SEC comments on the registration statement, not the registration statement itself or a financial report. Therefore, this is a Regulatory Filing (RNS) as it is a regulatory correspondence and does not fit other specific categories like Annual Report, Earnings Release, or Capital Update.
2011-06-22 English
TRAIL ONE, INC.
Capital/Financing Update Classification · 100% confidence The document is a Form S-1A Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes a preliminary prospectus, detailed company information, risk factors, management discussion and analysis, financial statements, and other disclosures related to the offering of common stock. This type of filing is related to capital raising activities and financing. It is not an annual report, earnings release, or any other type of report but specifically a registration statement for securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual filing, not just an announcement or certification.
2011-06-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.